Role of antimuscarinics in the treatment of nonneurogenic daytime urinary incontinence in children

Urology

Volumn 63, Issue 3 SUPPL. 1, 2004, Pages 45-50

  Nijman, Rien J M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIBIOTIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DARIFENACIN; DOXAZOSIN; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; SOLIFENACIN; TOLTERODINE;

ALLERGIC REACTION; BEHAVIOR THERAPY; BLADDER FILLING; CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DETRUSOR MUSCLE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG POTENCY; FEEDBACK SYSTEM; FLUSHING; FUNCTIONAL DISEASE; GENETIC PREDISPOSITION; HUMAN; IDIOPATHIC DISEASE; IMMATURITY; IMPAIRED BLADDER EMPTYING; MEDICAL ASSESSMENT; MICTURITION DISORDER; NERVE STIMULATION; NEUROLOGIC DISEASE; PELVIS FLOOR; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; RESIDUAL URINE; SEXUAL ABUSE; SIDE EFFECT; SKIN MANIFESTATION; THEORETICAL STUDY; URGE INCONTINENCE; URINARY TRACT INFECTION; URINE INCONTINENCE;

CHILD; HUMANS; MUSCARINIC ANTAGONISTS; PREVALENCE; URINARY INCONTINENCE;

EID: 1542268285     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2003.11.004     Document Type: Conference Paper

References (26)

1. Blomfield J.M., Douglas J.W.B. Bedwetting prevalence among children aged 4-7 years. Lancet. 1:1956;850-852.
2. Hellström A.-L., Hanson E., Hansson S., et al. Micturition habits and incontinence in 7-year-old Swedish school entrants. Eur J Pediatr. 149:1990;434-437.
3. Järvelin M.R., Vikeväinen-Tervonen L., Moilanen I., et al. Enuresis in seven-year-old children. Acta Paediatr Scand. 77:1988;148-153.
4. Lee S.D., Sohn D.W., Lee J.Z., et al. An epidemiological study of enuresis in Korean children. BJU Int. 85:2000;869-873.
5. Nevéus T., Hetta J., Cnattingius S., et al. Depth of sleep and sleep habits among enuretic and incontinent children. Acta Paediatr. 88:1999;748-752.
6. Nørgaard J.P., Van Gool J.D., Hjälmås K., et al. International Children's Continence Society. Standardization and definitions in lower urinary tract dysfunction in children. Br J Urol. 81:(suppl 3):1998;1-16.
7. Nijman R.J.M. Classification and treatment of functional incontinence in children. BJU Int. 85:(suppl 3):2000;37-42.
8. Nijman R.J.M. Neurogenic and non-neurogenic bladder dysfunction. Curr Opin Urol. 11:2001;577-583.
9. Schulman S.L., Quinn C.K., Plachter N., et al. Comprehensive management of dysfunctional voiding. Pediatrics. 103:1999;E31.
10. Hoebeke P., Van Laecke E., Van Camp C., et al. One thousand video-urodynamic studies in children with non-neurogenic bladder sphincter dysfunction. BJU Int. 87:2001;575-580.
11. Hinman F., Baumann F.W. Vesical and ureteral damage from voiding dysfunction in boys without neurologic or obstructive disease. J Urol. 109:1973;727-732.
12. Ellsworth P.I., Merguerian P.A., Copening M.E. Sexual abuse another causative factor in dysfunctional voiding. J Urol. 153:1995;773-776.
13. American Academy of Pediatrics Committee on Child Abuse and Neglect: Guidelines for the evaluation of sexual abuse of children: subject review (RE9819) [published erratum appears in Pediatrics 103: 1049, 1999]. Pediatrics 103: 186-191, 1999.
14. Wiener J.S., Scales M.T., Hampton J., et al. Long-term efficacy of simple behavioral therapy for daytime wetting in children. J Urol. 164:2000;786-790.
15. Vijverberg M.A., Elzinga-Plomp A., Messer A.P., et al. Bladder rehabilitation the effect of a cognitive training programme on urge incontinence. Eur Urol. 31:1997;68-72.
16. Hoebeke P., Van Laecke E., Everaert K., et al. Transcutaneous neuromodulation for the urge syndrome in children a pilot study. J Urol. 166:2001;2416-2419.
17. Hoebeke P., Renson C., Petillon L., et al. Percutaneous electrical nerve stimulation in children with therapy resistant nonneuropathic bladder sphincter dysfunction a pilot study. J Urol. 168:2002;2605-2608.
18. Hjälmås K., Hellström A.-L., Mogren K., et al. The overactive bladder in children a potential future indication for tolterodine. BJU Int. 87:2001;569-574.
19. Bolduc S., Upadhyay J., Payton J., et al. The use of tolterodine in children after oxybutynin failure. BJU Int. 91:2003;398-401.
20. Jonville A.P., Dutertre J.P., Barbellion M., et al. Adverse effects of oxybutynin chloride in pediatrics [in French]. Arch Fr Pediatr. 50:1993;27-29.
21. Nilvebrant L., Andersson K.E., Gillberg P.G., et al. Tolterodine a new bladder-selective antimuscarinic agent. Eur J Pharmacol. 327:1997;195-207.
22. Reinberg Y., Crocker J., Wolpert J., et al. Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence. J Urol. 169:2003;317-319.
23. Goessl C., Sauter T., Michael T., et al. Efficacy and tolerability of tolterodine in children with detrusor hyperreflexia. Urology. 55:2000;414-418.
24. Munding M., Wessells H., Thornberry B., et al. Use of tolterodine in children with dysfunctional voiding an initial report. J Urol. 165:2001;926-928.
25. Austin P.F., Homsy Y.L., Masel J.L., et al. Alpha-adrenergic blockade in children with neuropathic and nonneuropathic voiding dysfunction. BJU Int. 162:1999;1064-1067.
26. Curran M.J., Kaefer M., Peters C., et al. The overactive bladder in childhood long-term results with conservative management. J Urol. 163:2000;574-577.